These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 617782)

  • 1. Autoprothrombin ii-a, thrombin, and epinephrine: interrelated effects on platelet aggregation.
    Herman GE; Seegers WH; Henry RL
    Bibl Haematol; 1977; 44():21-7. PubMed ID: 617782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of autoprothrombin II-A on epinephrine-induced platelet aggregation of normal- and coumadin-treated dogs.
    Herman GE; Seegers WH; Henry RL
    Thromb Haemost; 1978 Aug; 40(1):61-5. PubMed ID: 725851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of activated protein C on platelet aggregation induced by thrombin.
    Novoa Santander E; Derpich Miranda L
    Acta Physiol Lat Am; 1983; 33(2):161-4. PubMed ID: 6422701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
    Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.
    Boyd DG; Davis RB
    Thromb Res; 1988 May; 50(3):429-36. PubMed ID: 3394122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological investigations on the adrenalin-thrombin-induced platelet aggregation in dogs].
    Nowak G; Glusa E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):831-9. PubMed ID: 2483700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion.
    Steen VM; Holmsen H
    Thromb Haemost; 1985 Oct; 54(3):680-3. PubMed ID: 4089798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation.
    Mehta P; Mehta J; Lawson D; Krop I; Letts LG
    Thromb Res; 1986 Mar; 41(5):731-8. PubMed ID: 3008372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs.
    Kristensen AT; Weiss DJ; Klausner JS
    J Vet Intern Med; 1994; 8(5):323-7. PubMed ID: 7837107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adrenaline-potentiated thrombin-induced reaction of human blood platelets by dihydroergotoxine.
    Barthel W; Hoffmann A; Markwardt F
    Acta Biol Med Ger; 1978; 37(7):1073-9. PubMed ID: 747039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation.
    Macfarlane DE; Walsh PN; Mills DC; Holmsen H; Day HJ
    Br J Haematol; 1975 Aug; 30(4):457-63. PubMed ID: 811245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation with epinephrine of macaque platelet aggregation by other agonists: implications for studies on human atherosclerosis.
    Beatty CH; Howard CF; Caruso V
    Thromb Res; 1986 Feb; 41(4):447-58. PubMed ID: 3083525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V; Heyns AD
    Thromb Res; 1990 Feb; 57(4):601-9. PubMed ID: 2158153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.